Jazz Pharmaceuticals idiopathic hypersomnia

Jazz Pharmaceuticals enrols first patient in Phase III JZP-258 trial

Jazz Pharmaceuticals has enrolled the first patient in a Phase III clinical trial to assess the efficacy and safety of…